608.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$618.92
Aprire:
$607.59
Volume 24 ore:
560.40K
Relative Volume:
1.09
Capitalizzazione di mercato:
$48.44B
Reddito:
$4.30B
Utile/perdita netta:
$1.06B
Rapporto P/E:
46.52
EPS:
13.0798
Flusso di cassa netto:
$1.04B
1 W Prestazione:
-7.36%
1M Prestazione:
-5.62%
6M Prestazione:
-5.38%
1 anno Prestazione:
+41.81%
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
608.41 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
501.97 | 194.93B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.50 | 142.84B | 24.57B | 3.60B | 5.26B | 5.051 |
|
A
Agilent Technologies Inc
|
115.07 | 33.38B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
302.54 | 30.96B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
IDEXX Laboratories (NASDAQ:IDXX) EVP Sells $1,115,574.06 in Stock - MarketBeat
Idexx Launch of InVue Provides Path to Recurring Revenue - Morningstar
IDEXX Laboratories, Inc. $IDXX Holdings Increased by Victory Capital Management Inc. - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Why Is Idexx (IDXX) Up 0.5% Since Last Earnings Report? - Yahoo Finance
New Age Alpha Advisors LLC Increases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) CEO Sells $15,338,011.30 in Stock - MarketBeat
IDEXX Laboratories CEO Jonathan Jay Mazelsky Sells Over 23,000 Shares - TradingView
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Shares Down 3.69% on Mar 2 - GuruFocus
IDEXX Labs at Raymond James Conference: Innovation and Growth Strategy - Investing.com Nigeria
Transcript : IDEXX Laboratories, Inc. Presents at 47th Annual Raymond James Institutional Investor Conference, Mar-02-2026 09 - marketscreener.com
IDEXX Laboratories Inc (IDXX) Stock Price & 30 Year Financial Data - GuruFocus
IDXX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IDEXX Laboratories, Inc. $IDXX Shares Sold by Davis R M Inc. - MarketBeat
Aster Capital Management DIFC Ltd Sells 3,735 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Analysis Recap: Can IDEXX Laboratories Inc keep up with sector leaders2025 Key Lessons & Proven Capital Preservation Tips - baoquankhu1.vn
William Blair Investment Management LLC Trims Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rafferty Asset Management LLC Sells 3,443 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Andra AP fonden Boosts Stake in IDEXX Laboratories - National Today
Erste Asset Management GmbH Sells 4,665 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Andra AP fonden Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
American Century Companies Inc. Has $450.52 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Wall Street Zen Downgrades IDEXX Laboratories (NASDAQ:IDXX) to Buy - MarketBeat
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit - MarketBeat
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 2,693 Shares of Stock - MarketBeat
IDEXX Laboratories Executive Sells Shares - TradingView
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
94,129 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Westfield Capital Management Co. LP - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stake Raised by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Reasons why hedge funds still fancy IDEXX Laboratories, Inc. (IDXX) - MSN
[144] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX Labs at BofA Summit: Strong Growth Amid Challenges - Investing.com Nigeria
Montrusco Bolton Investments Inc. Cuts Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
TD Asset Management Inc Sells 25,321 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790 - 富途牛牛
Investment Review: Can IDEXX Laboratories Inc sustain earnings growthQuarterly Portfolio Report & Weekly Breakout Watchlists - baoquankhu1.vn
IDXX SEC FilingsIDEXX Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan
Waratah Capital Advisors Ltd. Cuts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Weitz Investment Management Inc. Lowers Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Sells 6,794 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Dakota Wealth Management Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Up 3.23% on Feb 24 - GuruFocus
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why - MSN
Breakouts Watch: Is IDEXX Laboratories Inc attractive for institutional investorsWeekly Investment Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
LGT Capital Partners LTD. Reduces Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Generation Investment Management LLP Has $166.36 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX) - Finviz
Here's What Analysts Are Saying About IDEXX Laboratories (IDXX) - Bitget
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Idexx Laboratories Inc Azioni (IDXX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President |
Mar 03 '26 |
Sale |
634.57 |
1,758 |
1,115,577 |
18,141 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):